DM919

· D2M Biotherapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DM919, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1]